SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
path_2775_sm_supportinginformations.pdf932KSupporting Information
path_2775_sm_supportinginformations1.ppt2217KSupporting Information: Figure S1. Breast cancer-specific survival curve of Nottingham grade 1 (NGS-G1) stratified by combined mitotic index (M)/Bcl2 profile.
path_2775_sm_supportinginformations2.ppt2212KSupporting Information: Figure S2. Breast cancer-specific survival curve of Nottingham grade 3 (NGS-G3) stratified by mitotic index (M)/Bcl2 profile.
path_2775_sm_supportinginformations3.ppt2203KSupporting Information: Figure S3. Disease-specific survival curve of NGS-G2 stratified by combined mitotic index (M)/Bcl2 profile.
path_2775_sm_supportinginformations4.ppt2213KSupporting Information: Figure S4. (A) Clinical outcome of high-risk patients (NPI ≥ 3.4 and ER+) who received adjuvant hormone therapy according to mitotic index (M)/Bcl2 profile. (B) Disease-free survival curves of high-risk patients with M1–2/Bcl2+ phenotypes according to hormone adjuvant therapy status.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.